1. Home
  2. LYNX vs NKTR Comparison

LYNX vs NKTR Comparison

Compare LYNX & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyntris Inc. Common Stock

LYNX

Lyntris Inc. Common Stock

N/A

Current Price

$11.60

Market Cap

1.3B

Sector

Industrials

ML Signal

N/A

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

N/A

Current Price

$37.42

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LYNX
NKTR
Founded
2018
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2026
1996

Fundamental Metrics

Financial Performance
Metric
LYNX
NKTR
Price
$11.60
$37.42
Analyst Decision
Strong Buy
Buy
Analyst Count
7
15
Target Price
$19.67
★ $133.08
AVG Volume (30 Days)
347.4K
★ 891.5K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $307,711,000.00
Revenue This Year
$35.28
N/A
Revenue Next Year
$34.08
$27.72
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 86.00
52 Week Low
$10.27
$33.40
52 Week High
$14.64
$109.00

Technical Indicators

Market Signals
Indicator
LYNX
NKTR
Relative Strength Index (RSI) 47.11 33.05
Support Level $10.49 $35.61
Resistance Level $13.74 $39.89
Average True Range (ATR) 0.60 1.62
MACD 0.12 1.16
Stochastic Oscillator 64.00 39.35

Price Performance

Historical Comparison
LYNX
NKTR

About LYNX Lyntris Inc. Common Stock

Lyntris Inc is a defense technology company that develops connectivity solutions for military applications. Its products consist of interconnected subsystems designed to support defense and military customers in detecting threats, making decisions, and responding to operational requirements across multi-domain environments. The company serves U.S. and allied nation military customers. Its solutions are deployed across three core missions: Maritime Domain Awareness; Air & Missile Defense; and Space ISR & Resilient Communications. Maximum revenue is derived from the Maritime Domain Awareness business, which includes solutions focused on maritime monitoring, tracking and analysis that support government and defense customers in maintaining situational awareness across maritime environments.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: